Page last updated: 2024-09-04

ezetimibe and bezafibrate

ezetimibe has been researched along with bezafibrate in 6 studies

Compound Research Comparison

Studies
(ezetimibe)
Trials
(ezetimibe)
Recent Studies (post-2010)
(ezetimibe)
Studies
(bezafibrate)
Trials
(bezafibrate)
Recent Studies (post-2010) (bezafibrate)
2,4845631,4651,335267324

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Patel, J1
Critchley, WR; Shah, MK; Shaw, SM; Williams, SG; Yonan, N1
Abe, K; Taneyama, T; Teramoto, T1
Abe, M; Fukuda, N; Haketa, A; Hatanaka, Y; Kobayashi, H; Nakamura, Y; Soma, M; Tanaka, S; Tsunemi, A; Ueno, T1

Reviews

2 review(s) available for ezetimibe and bezafibrate

ArticleYear
Dyslipidaemia in diabetes.
    Clinical evidence, 2006, Issue:15

    Topics: Azetidines; Bezafibrate; Diabetes Complications; Diabetic Angiopathies; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin

2006
Second line options for hyperlipidemia management after cardiac transplantation.
    Cardiovascular therapeutics, 2013, Volume: 31, Issue:3

    Topics: Azetidines; Bezafibrate; Diet; Exercise; Ezetimibe; Fish Oils; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin

2013

Other Studies

4 other study(ies) available for ezetimibe and bezafibrate

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Safety and efficacy of long-term combination therapy with bezafibrate and ezetimibe in patients with dyslipidemia in the prospective, observational J-COMPATIBLE study.
    Cardiovascular diabetology, 2013, Nov-06, Volume: 12

    Topics: Aged; Azetidines; Bezafibrate; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Female; Humans; Hypolipidemic Agents; Japan; Lipids; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Time Factors; Treatment Outcome; Triglycerides

2013
Beyond statins: assessing the alternatives. Some people can't tolerate statins, and others need additional medications to achieve healthy cholesterol levels.
    Harvard heart letter : from Harvard Medical School, 2014, Volume: 25, Issue:3

    Topics: Anticholesteremic Agents; Azetidines; Bezafibrate; Cholesterol; Dietary Supplements; Exercise; Ezetimibe; Health Behavior; Health Promotion; Humans; Hyperlipidemias; Niacin

2014
Lipoprotein Lipase Deficiency Arising in Type V Dyslipidemia.
    Internal medicine (Tokyo, Japan), 2019, Jan-15, Volume: 58, Issue:2

    Topics: Adult; Age of Onset; Bezafibrate; Diabetes Complications; Ezetimibe; Genetic Variation; Heterozygote; Humans; Hyperlipoproteinemia Type I; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Lipoprotein Lipase; Male

2019